These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 19667666)

  • 1. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
    Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
    Fonarow GC
    Am J Med; 2004 Mar; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with beta blockers in advanced heart failure].
    Gronda E; Bologna A; Mangiavacchi M; Andreuzzi B
    Ital Heart J Suppl; 2000 Aug; 1(8):1011-8. PubMed ID: 10993007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diastolic heart failure].
    Smulders YM; Stehouwer CD; Bronzwaer JG; Kamp O
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2467-70. PubMed ID: 14708211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
    Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
    Pitt B; Fonarow GC; Gheorghiade M; Deedwania PC; Duprez DA
    Am J Cardiol; 2006 May; 97(10A):26F-33F. PubMed ID: 16698332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acute decompensated heart failure.
    Dec GW
    Curr Probl Cardiol; 2007 Jun; 32(6):321-66. PubMed ID: 17531903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blocker treatment in heart failure.
    Carson PE
    Prog Cardiovasc Dis; 1999; 41(4):301-21. PubMed ID: 10362350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.